The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage
Open accessAbstract
The spontaneous deamination of cytosine is a major source of transitions from C•G to T•A base pairs, which account for half of known pathogenic point mutations in humans. The ability to efficiently convert targeted A•T base pairs to G•C could therefore advance the study and treatment of genetic diseases. The deamination of adenine yields inosine, which is treated as guanine by polymerases, but no enzymes are known to deaminate adenine in DNA. Here we describe adenine base editors (ABEs) that mediate the conversion of A•T to G•C in genomic DNA. We evolved a transfer RNA adenosine deaminase to operate on DNA when fused to a catalytically impaired CRISPR-Cas9 mutant. Extensive directed evolution and protein engineering resulted in seventh-generation ABEs that convert targeted A•T base pairs efficiently to G•C (approximately 50% efficiency in human cells) with high product purity (typically at least 99.9%) and low rates of indels (typically no more than 0.1%). ABEs introduce point mutations more efficiently and cleanly, and with less off-target genome modification, than a current Cas9 nuclease-based method, and can install disease-correcting or disease-suppressing mutations in human cells. Together with previous base editors, ABEs enable the direct, programmable introduction of all four transition mutations without double-stranded DNA cleavage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Using a seventh-generation evolved transfer RNA adenosine deaminase attached to dCas9, researchers demonstrated conversion of A*T base pairs to G*C base pairs in a targeted fashion at efficiencies of around 50% with few undesired mutations in human cells.”
From Delivering CRISPR: a review of the challenges and approaches (2018) · cites this paper as Gaudelli et al., 2017
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Adenine base editor (ABE), first described in 2017, generally does not induce DSBs (<1%) and is therefore a favorable alternative to Cas9 for single and multiplex gene knockouts.12,14”
From Adenine base editor for knockout of proteins: A practical guide from design to analysis with updated MultiEditRbatch (2026) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Yet, these mutations occur significantly more often in human disease than transversion mutations (62% transition vs 38% transversion29,63).”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [29]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“CBE converts cytosine to thymine”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Gaudelli et al., 2017
The cited source says what the claim attributes to it.
In the citing paper
“ABE catalyzes the editing from adenine to guanine”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Gaudelli et al., 2017
The cited source says what the claim attributes to it.
In the citing paper
“Base editors are one such tool, which couple Cas9 nickases with nucleotide deaminases to achieve single nucleotide conversion without introducing DSBs.”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Gaudelli et al., 2017
The cited source says what the claim attributes to it.
In the citing paper
“Next-generation CRISPR tools, such as base editors, use enzymes like cytidine or adenine deaminases fused to Cas9 to introduce single nucleotide variants (SNVs) without DSBs.12,13”
From Protocol to create isogenic disease models from adult stem cell-derived organoids using next-generation CRISPR tools (2024) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“Fusing adenine deaminase (an evolved TadA heterodimer) to a nickase-Cas9 creates an adenine base editor (ABE) that mediates A > G base changes via an inosine intermediate29”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [29]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The second study used CRISPR-Cas9-mediated genome editing to remove a mutation in exon 23 in the mdx mouse model of DMD, providing partial recovery of functional dystrophin protein in skeletal myofibers and cardiac muscle 25,26,49 .”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [49]
Experimental — accuracy not yet measuredIn the citing paper
“Consistent with the literature1, ABE6.3 resulted in the highest A>G base editing efficiency at position A9 (6.9 ± 2.0%,2 µg ABE6.3) (Supplementary Fig. 1) and editing efficiency was dependent of the ABE enzyme concentration.”
From Adenine base editing in an adult mouse model of tyrosinaemia (2019) · cites this paper as [1]
In the citing paper
“Adenine BEs comprise an evolved Escherichia coli TadA (ecTadA*, a tRNA adenosine deaminase evolved to accept DNA substrate) and Cas9 nickase, and mediate A•T to G•C substitutions1.”
From Adenine base editing in an adult mouse model of tyrosinaemia (2019) · cites this paper as [1]
In the citing paper
“The ABE editing window occupies positions ~4–9 with the 1st, 5’ nucleotide (nt) of the candidate sgRNA counted as position 1 1.”
From Adenine base editing in an adult mouse model of tyrosinaemia (2019) · cites this paper as [1]
In the citing paper
“Point mutations are a frequent cause of genetic disease, with ~50% of disease point mutations being G:C>A:T 1.”
From Adenine base editing in an adult mouse model of tyrosinaemia (2019) · cites this paper as [1]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016) · Nature · doi:10.1038/nature17946 · Cited by 5,437
Self-citationClinVar: public archive of interpretations of clinically relevant variants
Landrum, M. J., Lee, J. M., Benson, M., Brown, G., Chao, C., Chitipiralla, S., Gu, B., Hart, J., Hoffman, D., Hoover, J., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1222 · Cited by 2,758
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
Tsai, S. Q., Zheng, Z., Nguyen, N. T., Liebers, M., Topkar, V. V., Thapar, V., Wyvekens, N., Khayter, C., Iafrate, A. J., Le, L. P., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3117 · Cited by 2,268
Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems
Nishida, K., Arazoe, T., Yachie, N., Banno, S., Kakimoto, M., Tabata, M., Mochizuki, M., Miyabe, A., Araki, M., Hara, K. Y., et al. (2016) · Science · doi:10.1126/science.aaf8729 · Cited by 1,349
Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9
Paquet, D., Kwart, D., Chen, A., Sproul, A., Jacob, S., Teo, S., Olsen, K. M., Gregg, A., Noggle, S., & Tessier-Lavigne, M. (2016) · Nature · doi:10.1038/nature17664 · Cited by 951
Precise base editing in rice, wheat and maize with a Cas9-cytidine deaminase fusion
Zong, Y., Wang, Y., Li, C., Zhang, R., Chen, K., Ran, Y., Qiu, J., Wang, D., & Gao, C. (2017) · Nature Biotechnology · doi:10.1038/nbt.3811 · Cited by 896
Komor, A. C., Zhao, K. T., Packer, M. S., Gaudelli, N. M., Waterbury, A. L., Koblan, L. W., Kim, Y. B., Badran, A. H., & Liu, D. R. (2017) · Science Advances · doi:10.1126/sciadv.aao4774 · Cited by 783
Self-citationKim, Y. B., Komor, A. C., Levy, J. M., Packer, M. S., Zhao, K. T., & Liu, D. R. (2017) · Nature Biotechnology · doi:10.1038/nbt.3803 · Cited by 758
Self-citationA system for the continuous directed evolution of biomolecules
Esvelt, K. M., Carlson, J. C., & Liu, D. R. (2011) · Nature · doi:10.1038/nature09929 · Cited by 694
Self-citationUracil in DNA – occurrence, consequences and repair
Krokan, H. E., Drabløs, F., & Slupphaug, G. (2002) · Oncogene · doi:10.1038/sj.onc.1205996 · Cited by 500
Flagged first, then by citations
Cited by
Sorted by citations
Items 701–800 of 1,024
Hematopoietic Stem Cell Gene-Addition/Editing Therapy in Sickle Cell Disease
Germino-Watnick, P., Hinds, M., Le, A., Chu, R., Liu, X., & Uchida, N. (2022) · Cells · doi:10.3390/cells11111843 · Cited by 63
Molecular basis of RADAR anti-phage supramolecular assemblies.
Gao, Y., Luo, X., Li, P., Li, Z.-L., Ye, F., Liu, S., & Gao, P. (2023) · Cell · doi:10.1016/j.cell.2023.01.026 · Cited by 62
Current trends of clinical trials involving CRISPR/Cas systems
Zhang, S., Wang, Y., Mao, D., Wang, Y., Zhang, H., Pan, Y., Wang, Y., Teng, S., & Huang, P. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1292452 · Cited by 62
AAV for Gene Therapy in Ocular Diseases: Progress and Prospects
He, X., Fu, Y., Ma, L., Yao, Y., Ge, S., Yang, Z. H., & Fan, X. (2023) · Research · doi:10.34133/research.0291 · Cited by 66
Progress in gene editing tools, implications and success in plants: a review
Bhuyan, S. J., Kumar, M., Devde, P. R., Rai, A. C., Mishra, A. K., Singh, P. K., & Siddique, K. H. M. (2023) · Frontiers in Genome Editing · doi:10.3389/fgeed.2023.1272678 · Cited by 61
High-fidelity SaCas9 identified by directional screening in human cells
Xie, H., Ge, X., Yang, F., Wang, B., Li, S., Duan, J., Lv, X., Cheng, C., Song, Z., Liu, C., et al. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000747 · Cited by 59
Progresses, Challenges, and Prospects of Genome Editing in Soybean (Glycine max)
Xu, H., Zhang, L., Zhang, K., & Ran, Y. (2020) · Frontiers in Plant Science · doi:10.3389/fpls.2020.571138 · Cited by 60
Chennakesavulu, K., Singh, H., Trivedi, P. K., Jain, M., & Yadav, S. R. (2022) · Plant Cell Reports · doi:10.1007/s00299-021-02681-w · Cited by 60
CRISPR/Cas systems: opportunities and challenges for crop breeding
Biswas, S., Zhang, D., & Shi, J. (2021) · Plant Cell Reports · doi:10.1007/s00299-021-02708-2 · Cited by 58
The Role of Recombinant AAV in Precise Genome Editing
Bijlani, S., Pang, K. M., Sivanandam, V., Singh, A., & Chatterjee, S. (2022) · Frontiers in Genome Editing · doi:10.3389/fgeed.2021.799722 · Cited by 63
de Boer, R. A., Heymans, S. R. B., Backs, J., Carrier, L., Coats, A. J. S., Dimmeler, S., Eschenhagen, T., Filippatos, G. S., Gepstein, L., Hulot, J., et al. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2414 · Cited by 59
WT-PE: Prime editing with nuclease wild-type Cas9 enables versatile large-scale genome editing
Tao, R. X., Wang, Y., Hu, Y. F., Jiao, Y., Zhou, L., Jiang, L., Li, L., He, X., Li, M., Yu, Y., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00936-w · Cited by 58
Current status and trends in forest genomics
Borthakur, D., Busov, V. B., Cao, H. X., Du, Q., Gailing, O., Işik, F., Ko, J., Li, C., Li, Q., Niu, S., et al. (2022) · Forestry Research · doi:10.48130/fr-2022-0011 · Cited by 58
A prime editor mouse to model a broad spectrum of somatic mutations in vivo
Ely, Z. A., Mathey‐Andrews, N., Naranjo, S., Gould, S. I., Mercer, K. L., Newby, G. A., Cabana, C. M., Rideout, W. M., Jaramillo, G. C., Khirallah, J., et al. (2023) · Nature Biotechnology · doi:10.1038/s41587-023-01783-y · Cited by 63
Self-citationNanobiomaterial vectors for improving gene editing and gene therapy
Hu, S. W., Ding, T., Tang, H., Guo, H., Cui, W., & Shu, Y. (2023) · Materials Today · doi:10.1016/j.mattod.2023.04.011 · Cited by 58
A review on CRISPR/Cas: a versatile tool for cancer screening, diagnosis, and clinic treatment
Yang, X., & Zhang, B. (2023) · Functional & Integrative Genomics · doi:10.1007/s10142-023-01117-w · Cited by 58
Hou, P., del Agua, N. T., Lwin, S. M., Hsu, C., & McGrath, J. A. (2023) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s386923 · Cited by 60
Wu, Y., Wan, X., Zhao, D., Chen, X., Wang, Y., Tang, X., Li, J., Li, S., Sun, X., Bi, C., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40655-6 · Cited by 59
Epigenome editing for targeted DNA (de)methylation: a new perspective in modulating gene expression
Seem, K., Kaur, S., Kumar, S., & Mohapatra, T. (2024) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2024.2320659 · Cited by 59
Lipid Nanoparticles for Delivery of CRISPR Gene Editing Components
Wu, F., Li, N., Xiao, Y., Palanki, R., Yamagata, H. M., Mitchell, M. J., & Han, X. (2025) · Small Methods · doi:10.1002/smtd.202401632 · Cited by 64
Precision Breeding Made Real with CRISPR: Illustration through Genetic Resistance to Pathogens
Veillet, F., Durand, M., Kroj, T., Césari, S., & Gallois, J. (2020) · Plant Communications · doi:10.1016/j.xplc.2020.100102 · Cited by 60
Advances in Genome Editing and Application to the Generation of Genetically Modified Rat Models
Chenouard, V., Remy, S., Tesson, L., Ménoret, S., Ouisse, L.-H., Cherifi, Y., & Anegon, I. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.615491 · Cited by 57
An adenine base editor with expanded targeting scope using SpCas9‐NG v1 in rice
Negishi, K., Kaya, H., Abe, K., Hara, N., Saika, H., & Toki, S. (2019) · Plant Biotechnology Journal · doi:10.1111/pbi.13120 · Cited by 57
In vivo functional screening for systems-level integrative cancer genomics
Weber, J., Braun, C. J., Saur, D., & Rad, R. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-0275-9 · Cited by 60
CRISPR-based gene expression control for synthetic gene circuits
Santos‐Moreno, J., & Schaerli, Y. (2020) · Biochemical Society Transactions · doi:10.1042/bst20200020 · Cited by 59
Schmidt, M. J., Gupta, A. K., Bednarski, C., Gehrig-Giannini, S., Richter, F. M., Pitzler, C., Gamalinda, M., Galonska, C., Takeuchi, R., Wang, K., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24454-5 · Cited by 58
Targeting Cancer with CRISPR/Cas9-Based Therapy
Balon, K., Sheriff, A., Jackow, J., & Łaczmański, Ł. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23010573 · Cited by 60
Sun, T., Song, J., Wang, M., Chao, Z., & Zhang, W. (2022) · Journal of Biosafety and Biosecurity · doi:10.1016/j.jobb.2022.02.002 · Cited by 58
Foley, R. A., Sims, R. A., Duggan, E. C., Olmedo, J. K., Ma, R., & Jonas, S. J. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.973326 · Cited by 60
Crop bioengineering via gene editing: reshaping the future of agriculture
Atia, M. A. M., Jiang, W., Sedeek, K., Butt, H., & Mahfouz, M. M. (2024) · Plant Cell Reports · doi:10.1007/s00299-024-03183-1 · Cited by 59
Masarwy, R., Stotsky‐Oterin, L., Elisha, A., Hazan‐Halevy, I., & Peer, D. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115359 · Cited by 59
Enhancing precision in cancer treatment: the role of gene therapy and immune modulation in oncology
Youssef, E. M., Fletcher, B., & Palmer, D. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2024.1527600 · Cited by 63
Targeting KRAS mutations: orchestrating cancer evolution and therapeutic challenges
Choucair, K., Imtiaz, H., Uddin, M. H., Nagasaka, M., Al-Hallak, M. N., Philip, P. A., El-Rayes, B., Pasche, B., & Azmi, A. S. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02473-8 · Cited by 67
Klompe, S. E., & Sternberg, S. H. (2018) · The CRISPR Journal · doi:10.1089/crispr.2018.0012 · Cited by 57
Precision gene editing technology and applications in nephrology
WareJoncas, Z., Campbell, J. M., Martínez‐Gálvez, G., Gendron, W. A. C., Barry, M. A., Harris, P. C., Sussman, C. R., & Ekker, S. C. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0047-x · Cited by 61
Diakatou, M., Manès, G., Bocquet, B., Meunier, I., & Kalatzis, V. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102542 · Cited by 59
Bae, S., Park, B. G., Kim, B., & Hahn, J. (2019) · Biotechnology Journal · doi:10.1002/biot.201900238 · Cited by 57
SNP-CRISPR: A Web Tool for SNP-Specific Genome Editing
Chen, C., Rodiger, J., Chung, V., Viswanatha, R., Mohr, S. E., Hu, Y., & Perrimon, N. (2019) · G3 Genes Genomes Genetics · doi:10.1534/g3.119.400904 · Cited by 57
Cytosine base editor 4 but not adenine base editor generates off-target mutations in mouse embryos
Lee, H., Smith, H. E., Liu, C., Willi, M., & Hennighausen, L. G. (2020) · Communications Biology · doi:10.1038/s42003-019-0745-3 · Cited by 61
BEAT: A Python program to quantify base editing from Sanger sequencing
Xu, L., Liu, Y., & Han, R. (2019) · The CRISPR Journal · doi:10.1089/crispr.2019.0017 · Cited by 56
Stargardt disease and progress in therapeutic strategies
Huang, D., Jeffery, R. C. H., Aung-Htut, M. T., McLenachan, S., Fletcher, S., Wilton, S. D., & Chen, F. K. (2021) · Ophthalmic Genetics · doi:10.1080/13816810.2021.1966053 · Cited by 57
Li, M., Zhong, A., Wu, Y., Sidharta, M., Beaury, M. W., Zhao, X., Studer, L., & Zhou, T. (2022) · Nature Communications · doi:10.1038/s41467-022-34045-7 · Cited by 57
Nayeri, S., Dehghanian, Z., Lajayer, B. A., Thomson, A., Astatkie, T., & Price, G. W. (2023) · Journal of Cleaner Production · doi:10.1016/j.jclepro.2023.139512 · Cited by 57
Fan, T., Cheng, Y., Wu, Y., Liu, S., Tang, X. D., He, Y., Liao, S., Zheng, X., Zhang, T., Qi, Y., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49473-w · Cited by 59
Engineered nucleocytosolic vehicles for loading of programmable editors
Geilenkeuser, J., Armbrust, N., Steinmaßl, E., Du, S. W., Schmidt, S., Binder, E. M. H., Li, Y., Warsing, N. W., Wendel, S. V., von der Linde, F., et al. (2025) · Cell · doi:10.1016/j.cell.2025.03.015 · Cited by 58
Development of Highly Efficient Dual‐AAV Split Adenosine Base Editor for In Vivo Gene Therapy
Chen, Y., Zhi, S., Liu, W., Wen, J., Hu, S., Cao, T., Sun, H., Li, Y., Huang, L. T., Liu, Y., et al. (2020) · Small Methods · doi:10.1002/smtd.202000309 · Cited by 57
Directed Evolution of CRISPR/Cas Systems for Precise Gene Editing
Liu, R., Liang, L., Freed, E. F., & Gill, R. T. (2020) · Trends in biotechnology · doi:10.1016/j.tibtech.2020.07.005 · Cited by 58
Single-nucleotide-level mapping of DNA regulatory elements that control fetal hemoglobin expression
Cheng, L., Li, Y., Qi, Q., Xu, P., Feng, R., Palmer, L. E., Chen, J., Wu, R., Yee, T., Zhang, J., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00861-8 · Cited by 59
Yuan, T., Yan, N., Fei, T., Zheng, J., Meng, J., Li, N., Liu, J., Zhang, H., Xie, L., Ying, W., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25217-y · Cited by 55
Marx, V. (2018) · Nature Methods · doi:10.1038/s41592-018-0146-4 · Cited by 55
Methods and applications of CRISPR/Cas system for genome editing in stem cells
Yang, G., & Huang, X. (2019) · Cell Regeneration · doi:10.1016/j.cr.2019.08.001 · Cited by 55
CRISPR-induced indels and base editing using the Staphylococcus aureus Cas9 in potato
Veillet, F., Kermarrec, M.-P., Chauvin, L., Chauvin, J.-É., & Nogué, F. (2020) · PLoS ONE · doi:10.1371/journal.pone.0235942 · Cited by 55
From Genome Sequencing to CRISPR-Based Genome Editing for Climate-Resilient Forest Trees
Cao, H. X., Vu, G. T. H., & Gailing, O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020966 · Cited by 56
Efficient Genome Editing in Setaria italica Using CRISPR/Cas9 and Base Editors
Liang, Z., Wu, Y., Ma, L., Guo, Y., & Ran, Y. (2022) · Frontiers in Plant Science · doi:10.3389/fpls.2021.815946 · Cited by 55
Systematic decomposition of sequence determinants governing CRISPR/Cas9 specificity
Fu, R., He, W., Dou, J., Villarreal, O. D., Bedford, E., Wang, H. H., Hou, C., Zhang, L., Wang, Y., Ma, D., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28028-x · Cited by 59
A precise and efficient adenine base editor
Tu, T., Song, Z., Liu, X., Wang, S., He, X., Xi, H., Wang, J., Yan, T., Chen, H., Zhang, Z., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.07.010 · Cited by 55
DNA base editing in nuclear and organellar genomes
Tan, J., Forner, J., Karcher, D., & Bock, R. (2022) · Trends in Genetics · doi:10.1016/j.tig.2022.06.015 · Cited by 57
Precision genome editing in the eye
Suh, S., Choi, E. H., Raguram, A., Liu, D. R., & Palczewski, K. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2210104119 · Cited by 56
Self-citationCurrent advancement in the application of prime editing
Huang, Z., & Liu, G. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1039315 · Cited by 56
Manzoor, S., Nabi, S. U., Rather, T. R., Gani, G., Mir, Z. A., Wani, A. W., Ali, S., Tyagi, A., & Manzar, N. (2024) · Frontiers in Genome Editing · doi:10.3389/fgeed.2024.1399051 · Cited by 58
In vivo base editing extends lifespan of a humanized mouse model of prion disease
An, M., Davis, J. R., Levy, J. M., Serack, F. E., Harvey, J. W., Brauer, P. P., Pirtle, C. P., Berríos, K. N., Newby, G. A., Yeh, W.-H., et al. (2025) · Nature Medicine · doi:10.1038/s41591-024-03466-w · Cited by 58
Self-citationNoncoding RNAs as therapeutic targets in early stage diabetic kidney disease
Kato, M. V. (2018) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.2018.37.3.197 · Cited by 56
Targeted exon skipping with AAV-mediated split adenine base editors
Winter, J., Luu, A., Gapinske, M., Manandhar, S., Shirguppe, S., Woods, W. S., Song, J. S., & Pérez‐Piñera, P. (2019) · Cell Discovery · doi:10.1038/s41421-019-0109-7 · Cited by 56
CRISPR technologies for the treatment of Duchenne muscular dystrophy
Choi, E., & Koo, T. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.04.002 · Cited by 57
Zhang, Y., Cheng, Y., Fang, H., Roberts, N., Zhang, L., Vakulskas, C. A., Niedz, R. P., Culver, J. N., & Qi, Y. (2022) · Frontiers in Genome Editing · doi:10.3389/fgeed.2022.780238 · Cited by 55
Single-Base Resolution: Increasing the Specificity of the CRISPR-Cas System in Gene Editing
Rabinowitz, R., & Offen, D. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.11.009 · Cited by 58
Niu, Q., Wu, S., Xie, H., Wu, Q., Liu, P., Xu, Y., & Lang, Z. (2021) · Plant Biotechnology Journal · doi:10.1111/pbi.13736 · Cited by 54
Gene Therapy for Cardiovascular Disease: Basic Research and Clinical Prospects
Cao, G., Xuan, X., Zhang, R., Hu, J. H., & Dong, H. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.760140 · Cited by 58
In vivo hypermutation and continuous evolution
Molina, R. S., Rix, G., Mengiste, A. A., Álvarez, B., Seo, D., Chen, H., Hurtado, J., Zhang, Q., García-García, J. D., Heins, Z., et al. (2022) · Nature Reviews Methods Primers · doi:10.1038/s43586-022-00130-w · Cited by 54
Towards next-generation cell factories by rational genome-scale engineering
Yilmaz, S., Nyerges, Á., John van der, O. O. S. T., Church, G. M., & Claassens, N. J. (2022) · Nature Catalysis · doi:10.1038/s41929-022-00836-w · Cited by 56
Decorating chromatin for enhanced genome editing using CRISPR-Cas9
Chen, E., Lin-Shiao, E., Trinidad, M. I., Doost, M. S., Colognori, D., & Doudna, J. A. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2204259119 · Cited by 57
Intelligent nanotherapeutic strategies for the delivery of CRISPR system
Chen, C., Zhong, W., Du, S., Li, Y., Zeng, Y., Liu, K., Yang, J., Guan, X., & Han, X. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.12.013 · Cited by 56
Rapid and definitive treatment of phenylketonuria in variant-humanized mice with corrective editing
Brooks, D. L., Carrasco, M. J., Qü, P., Peranteau, W. H., Ahrens‐Nicklas, R. C., Musunuru, K., Alameh, M., & Wang, X. (2023) · Nature Communications · doi:10.1038/s41467-023-39246-2 · Cited by 54
Efficient plant genome engineering using a probiotic sourced CRISPR-Cas9 system
Zhong, Z., Liu, G., Tang, Z., Xiang, S., Yang, L., Huang, L., He, Y., Fan, T., Liu, S., Zheng, X., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41802-9 · Cited by 58
Genome Editing of Plant Mitochondrial and Chloroplast Genomes
Arimura, S., & Nakazato, I. (2023) · Plant and Cell Physiology · doi:10.1093/pcp/pcad162 · Cited by 54
Biology and applications of CRISPR–Cas12 and transposon-associated homologs
Wu, W. Y., Adiego-Pérez, B., & John van der, O. O. S. T. (2024) · Nature Biotechnology · doi:10.1038/s41587-024-02485-9 · Cited by 58
Chemical engineering of CRISPR–Cas systems for therapeutic application
Barber, H. M., Pater, A. A., Gagnon, K. T., Damha, M. J., & O’Reilly, D. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01086-0 · Cited by 57
Advancing Metabolic Engineering of Saccharomyces cerevisiae Using the CRISPR/Cas System
Lian, J., HamediRad, M., & Zhao, H. (2018) · Biotechnology Journal · doi:10.1002/biot.201700601 · Cited by 54
Targeted Nucleotide Editing Technologies for Microbial Metabolic Engineering
Arazoe, T., Kondo, A., & Nishida, K. (2018) · Biotechnology Journal · doi:10.1002/biot.201700596 · Cited by 54
Base pair editing in goat: nonsense codon introgression into FGF 5 results in longer hair
Li, G., Zhou, S., Li, C., Cai, B., Yu, H., Ma, B., Huang, Y. S., Ding, Y., Liu, Y., Ding, Q., et al. (2019) · FEBS Journal · doi:10.1111/febs.14983 · Cited by 54
Computational Tools and Resources Supporting CRISPR-Cas Experiments
Śledziński, P., Nowaczyk, M., & Olejniczak, M. (2020) · Cells · doi:10.3390/cells9051288 · Cited by 57
Repurposing type I–F CRISPR–Cas system as a transcriptional activation tool in human cells
Chen, Y., Liu, J., Zhi, S., Zheng, Q., Ma, W., Huang, J., Liu, Y., Liu, D., Liang, P., & Songyang, Z. (2020) · Nature Communications · doi:10.1038/s41467-020-16880-8 · Cited by 54
Self-citationApplications of CRISPR technology in studying plant-pathogen interactions: overview and perspective
Gosavi, G., Yan, F., Ren, B., Kuang, Y., Yan, D., Zhou, X., & Zhou, H. (2020) · Phytopathology Research · doi:10.1186/s42483-020-00060-z · Cited by 56
CRISPR technology: The engine that drives cancer therapy
Zhang, M., Eshraghian, E. A., Jammal, O. A., Zhang, Z.-B., & Zhu, X. M. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111007 · Cited by 54
Findlay, G. M. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab219 · Cited by 58
Brookhouser, N., Tekel, S. J., Standage-Beier, K., Nguyen, T., Schwarz, G., Wang, X., & Brafman, D. A. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.12.013 · Cited by 53
State-of-the-art CRISPR for in vivo and cell-based studies in Drosophila
Zirin, J. D., Bosch, J. A., Viswanatha, R., Mohr, S. E., & Perrimon, N. (2021) · Trends in Genetics · doi:10.1016/j.tig.2021.11.006 · Cited by 58
Towards quantitative and multiplexed in vivo functional cancer genomics
Winters, I. P., Murray, C. W., & Winslow, M. M. (2018) · Nature Reviews Genetics · doi:10.1038/s41576-018-0053-7 · Cited by 54
CRISPR mediated genome engineering to develop climate smart rice: Challenges and opportunities
Biswal, A. K., Mangrauthia, S. K., Reddy, M. R., & Yugandhar, P. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.04.005 · Cited by 56
Adenovirus vectors in hematopoietic stem cell genome editing
Li, C., & Lieber, A. (2019) · FEBS Letters · doi:10.1002/1873-3468.13668 · Cited by 53
Precise base editing with CC context-specificity using engineered human APOBEC3G-nCas9 fusions
Liu, Z., Chen, S., Shan, H., Jia, Y., Chen, M., Song, Y., Lai, L., & Li, Z. (2020) · BMC Biology · doi:10.1186/s12915-020-00849-6 · Cited by 53
Approach for in vivo delivery of CRISPR/Cas system: a recent update and future prospect
Chuang, Y.-F., Phipps, A. J., Lin, F., Hecht, V. F. G., Hewitt, A. W., Wang, P., & Liu, G. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03725-2 · Cited by 53
Nonviral genome engineering of natural killer cells
Robbins, G. M., Wang, M., Pomeroy, E. J., & Moriarity, B. S. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02406-6 · Cited by 57
High-efficiency base editing in the retina in primates and human tissues
Muller, A., Sullivan, J., Schwarzer, W., Wang, M., Park-Windhol, C., Hasler, P. W., Janeschitz-Kriegl, L., Duman, M., Klingler, B., Matsell, J., et al. (2025) · Nature Medicine · doi:10.1038/s41591-024-03422-8 · Cited by 52
Self-citationCRISPR-derived genome editing technologies for metabolic engineering
Nishida, K., & Kondo, A. (2020) · Metabolic Engineering · doi:10.1016/j.ymben.2020.12.002 · Cited by 54
Novel plant breeding techniques to advance nitrogen use efficiency in rice: A review
Fiaz, S., Wang, X., Khan, S. A., Ahmar, S., Noor, M. A., Riaz, A., Ali, K., Abbas, F., Mora, F., Figueroa, C. R., et al. (2021) · GM crops & food · doi:10.1080/21645698.2021.1921545 · Cited by 52
Base editing in human cells with monomeric DddA-TALE fusion deaminases
Mok, Y. G., Lee, J. M., Chung, E., Lee, J., Lim, K., Cho, S.-I., & Kim, J. (2022) · Nature Communications · doi:10.1038/s41467-022-31745-y · Cited by 52
Hypercompact adenine base editors based on a Cas12f variant guided by engineered RNA
Kim, D. Y., Chung, Y., Lee, Y., Jeong, D., Park, K., Chin, H. J., Lee, J. M., Park, S., Ko, S., Ko, J., et al. (2022) · Nature Chemical Biology · doi:10.1038/s41589-022-01077-5 · Cited by 52
Prokaryotic Argonaute Proteins as a Tool for Biotechnology
Kropocheva, E., Lisitskaya, L., Agapov, A., Musabirov, A. A., Kulbachinskiy, A. V., & Esyunina, D. (2022) · Molecular Biology · doi:10.1134/s0026893322060103 · Cited by 54
Gene therapy for inborn errors of immunity: past, present and future
Fischer, A. (2022) · Nature reviews. Immunology · doi:10.1038/s41577-022-00800-6 · Cited by 54
Metadata
- Authors
- Gaudelli, N. M., Komor, A. C., Rees, H. A., Packer, M. S., Badran, A. H., Bryson, D. I., & Liu, D. R.
- Affiliations
- Broad Institute (US)
- Corresponding author
- Liu, David R.
- ORCID
- Venue
- Nature
- Published
- 2017-11-01
- Volume
- 551
- Issue
- 7681
- Pages
- 464-471
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC5726555
- OpenAlex
- W2766599608
- Cited by
- 4,184
- References
- 46
- Citations by year
- 2026: 460 · 2025: 501 · 2024: 521 · 2023: 599 · 2022: 557 · 2021: 489 · 2020: 474 · 2019: 332 · 2018: 237 · 2017: 8
- FWCI
- 117.56
- Type
- journal article
- Language
- en
- Update notices
- correction (2018-05-02)
- Open access
- green
- europepmc.org
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Human Genome Research Institute (RM1HG009490)
- National Institute of General Medical Sciences (T32GM008313, F32GM106621, R35GM118062, F32GM112366)
- National Institute of Biomedical Imaging and Bioengineering (R01EB022376)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- adenine base editors, base editing, cytosine deamination, CRISPR/Cas9, directed evolution, protein engineering, transition mutations, point mutations, single nucleotide polymorphisms
- MeSH terms
- Gene Editing, Adenosine Deaminase, DNA, Humans, Models, Molecular, Genome, Human, Base Pairing, Polymorphism, Single Nucleotide, Cell Line, Tumor, DNA Cleavage, HEK293 Cells, CRISPR-Associated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
